| ²é¿´: 2968 | »Ø¸´: 6 | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
kabuqinuo89гæ (СÓÐÃûÆø)
|
[ÇóÖú]
DNAƬ¶ÎÁ¬½Óµ½ÔØÌåÉ϶¼ÓÐʲô·½·¨
|
||
| ½«Ä¿µÄƬ¶ÎÁ¬½Óµ½ÔØÌåÉÏ£¬³ýÁË˫øÇл¹ÓÐʲô±ðµÄ·½·¨Ã» |
» ²ÂÄãϲ»¶
Wnt-C59£ºPORCN°ÐÏò»¯Ñ§Ì½Õ룬WntÐźÅͨ·×è¶Ï»úÖÆÓë¿ÆÑÐÓ¦ÓÃÈ«½âÎö
ÒѾÓÐ0È˻ظ´
Fexaramine£º³¦µÀÏÞÖÆÐÔFXR»¯Ñ§Ì½Õ룬½á¹¹ÌØÕ÷ÓëÐźÅͨ·Ñо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
»¯Ñ§¹¤³Ì¼°¹¤Òµ»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ143È˻ظ´
NVS-STG2£º°ÐÏòSTING¿çĤÓòµÄ·Ö×Ó½ºÀ༤¶¯¼Á£¬½á¹¹ÌØÕ÷Óë¹Ñ¾Û»¯»úÖÆÑо¿È«½âÎö
ÒѾÓÐ0È˻ظ´
DOTA-GPC3ëÄ£¨CAS 3066439-94-6£©£ºË«¹¦ÄÜ·Ö×Ó̽ÕëǰÌåµÄ½á¹¹ÌØÕ÷Óë±ê¼ÇÓ¦ÓýâÎö
ÒѾÓÐ0È˻ظ´
¿ÆÑÐÓà TLR7/8 Ë«¼¤¶¯¼ÁÔõôѡ£¿ÏÖ»õÓëÖÊ¿ØÒªµã
ÒѾÓÐ0È˻ظ´
SEL120-34A HCl£ºCDK8/CDK19¸ßÑ¡ÔñÐÔ¼¤Ã¸ÒÖÖÆ¼Á
ÒѾÓÐ0È˻ظ´
ÇâÑõ»¯¼Ø»î»¯²Ù×÷
ÒѾÓÐ18È˻ظ´
É¢½ð
ÒѾÓÐ68È˻ظ´
ÉúÎïÖʳ¬¼¶µçÈÝÆ÷
ÒѾÓÐ0È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Ä¿µÄ»ùÒòÁ¬½Óµ½¿ËÂ¡ÔØÌåºóÌáÈ¡ÖÊÁ£²âÐò£¬ÐòÁÐÓÐÎÊÌâ
ÒѾÓÐ11È˻ظ´
ÔØÌåºÍøÇÐÆ¬¶ÎÁ¬½ÓµÄÎÊÌâ
ÒѾÓÐ5È˻ظ´
Ä¿µÄƬ¶ÎÓëÔØÌåÁ¬½ÓºóÎÞ·¨¼ì²â³ö
ÒѾÓÐ7È˻ظ´
ÔØÌå×ÜÊÇÁ¬²»ÉÏ£¬ÒѾһ¸öÔÂÁË~ÕæÐÄÇóÖú£¬ÏêϸÔÚÌû×ÓÀï
ÒѾÓÐ7È˻ظ´
ÐéÐÄÇë½Ì¹ØÓÚÆ½¡ªÕ³Ä©¶ËµÄÁ¬½ÓÎÊÌâ
ÒѾÓÐ18È˻ظ´
¹¹½¨pBI121±í´ïÔØÌ壬ĿµÄ»ùÒòÓëÔØÌåÁ¬½Ó²»ÉÏ
ÒѾÓÐ54È˻ظ´
Ä¿µÄƬ¶ÎÓë±í´ïÔØÌåµÄÁ¬½Ó
ÒѾÓÐ23È˻ظ´
DNAµÄÁ¬½Ó·´Ó¦
ÒѾÓÐ5È˻ظ´
ÔØÌåÁ¬½ÓpcrƬ¶ÎÒ»Ö±Á¬²»ÉÏ
ÒѾÓÐ17È˻ظ´
PCR £¬ ˫øÇУ¬Á¬½ÓÎÊÌâ
ÒѾÓÐ17È˻ظ´
³¤Æ¬¶ÎDNAÈçºÎÁ¬½ÓÔØÌå
ÒѾÓÐ21È˻ظ´
¡¾ÇóÖú¡¿»ùÒò¿Ë¡TÔØÌåøÇÐÎÊÌâµÈ
ÒѾÓÐ8È˻ظ´
ÔØÌåÁ¬½Ó
ÒѾÓÐ7È˻ظ´
¿Ë¡»ùÒòÁ¬½Óµ½ÔØÌåÉϲâÐò·¢ÏÖÓÐÒ»¸öµãÍ»±äÔõô°ì£¿
ÒѾÓÐ16È˻ظ´
ÎÒÓõÄÊÇpMAL-m2ÔØÌ壬Ƭ¶Î´óСÁ¬²»ÉÏ£¡
ÒѾÓÐ3È˻ظ´
¿Ë¡»ùÒòºÍÔØÌåÁ¬½Óºóת»¯ÖÁ´ó³¦¸Ë¾ú£¬ÎªÊ²Ã´Ã¿´ÎÍ¿°å¶¼ÊÇ¿ÕÆ½°åûÓоúÂ䣿
ÒѾÓÐ17È˻ظ´
stevenshi021
гæ (СÓÐÃûÆø)
- Ó¦Öú: 61 (³õÖÐÉú)
- ½ð±Ò: 545.3
- ºì»¨: 5
- Ìû×Ó: 276
- ÔÚÏß: 35.1Сʱ
- ³æºÅ: 2272292
- ×¢²á: 2013-02-03
- רҵ: ÉúÎﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
|
Biotechniques. 2010 Jun;48(6):463-5. doi: 10.2144/000113418. Overlap extension PCR cloning: a simple and reliable way to create recombinant plasmids. http://www.ncbi.nlm.nih.gov/pubmed/20569222 |
6Â¥2013-05-29 09:14:28
peng~yu
Òø³æ (СÓÐÃûÆø)
- MolEPI: 3
- Ó¦Öú: 11 (СѧÉú)
- ½ð±Ò: 736.3
- É¢½ð: 100
- ºì»¨: 4
- Ìû×Ó: 103
- ÔÚÏß: 52.1Сʱ
- ³æºÅ: 1276154
- ×¢²á: 2011-04-24
- ÐÔ±ð: GG
- רҵ: ÉúÎﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
kabuqinuo89(myprayer´ú·¢): ½ð±Ò+1, ÔùÈËõ¹åÊÖÓÐÓàÏ㣬¸ÐлÄãµÄ¿¶¿®½âÄÒ£¬ÆÚ´ýÄãµÄ¾«²Ê¡£ 2013-05-28 10:35:08
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
kabuqinuo89(myprayer´ú·¢): ½ð±Ò+1, ÔùÈËõ¹åÊÖÓÐÓàÏ㣬¸ÐлÄãµÄ¿¶¿®½âÄÒ£¬ÆÚ´ýÄãµÄ¾«²Ê¡£ 2013-05-28 10:35:08
| ÎÒÃÇʵÑéÊÒÒ»°ã¶¼ÊÇÓÃ˫øÇеķ½·¨È¥Á¬~¸Ð¾õÎÊÌâ²»´ó~ÕâÖÖ·½·¨Ò²ÊÇͦ³ÉÊìµÄÒ»Ì×·½·¨~»òÕßÄã¿ÉÒԲο¼×ª»ùÒò×÷ÎïµÄÑз¢ÀúÊ·~²»¹ýÎÒ¾õµÃÕâÑùÓеã´ó²ÄСÓÃ~ |
2Â¥2013-05-28 09:56:59
stevenshi021
гæ (СÓÐÃûÆø)
- Ó¦Öú: 61 (³õÖÐÉú)
- ½ð±Ò: 545.3
- ºì»¨: 5
- Ìû×Ó: 276
- ÔÚÏß: 35.1Сʱ
- ³æºÅ: 2272292
- ×¢²á: 2013-02-03
- רҵ: ÉúÎﻯѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
kabuqinuo89(myprayer´ú·¢): ½ð±Ò+1, ¸ÐлÄãµÄ¿¶¿®½âÄÒ£¬ÆÚ´ýÄãµÄ¾«²Ê¡£ 2013-05-28 10:35:21
kabuqinuo89: ½ð±Ò+2 2013-05-28 15:36:27
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
kabuqinuo89(myprayer´ú·¢): ½ð±Ò+1, ¸ÐлÄãµÄ¿¶¿®½âÄÒ£¬ÆÚ´ýÄãµÄ¾«²Ê¡£ 2013-05-28 10:35:21
kabuqinuo89: ½ð±Ò+2 2013-05-28 15:36:27
| overlap PCT and inverse-overlap PCR(http://www.biotechniques.com/mul ... _Materi_96566a.pdf) |
3Â¥2013-05-28 10:03:57
whb21
ľ³æ (ÖøÃûдÊÖ)
- MolEPI: 1
- Ó¦Öú: 105 (¸ßÖÐÉú)
- ½ð±Ò: 9711.3
- É¢½ð: 625
- ºì»¨: 7
- Ìû×Ó: 2994
- ÔÚÏß: 172.4Сʱ
- ³æºÅ: 928584
- ×¢²á: 2009-12-15
- ÐÔ±ð: GG
- רҵ: ΢ÉúÎïÉúÀíÓëÉúÎﻯѧ
4Â¥2013-05-28 12:48:59









»Ø¸´´ËÂ¥
ͶƱ: